Dr. Strauss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8220 Walnut Hill Ln
Dallas, TX 75231Phone+1 214-739-4175Fax+1 214-987-4161
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1979
- Baylor University Medical CenterResidency, Internal Medicine, 1974 - 1976
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1972 - 1973
- New York University School of MedicineClass of 1972
Certifications & Licensure
- TX State Medical License 1974 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsTherapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levelsIsabel Kurth, Norihiro Yamaguchi, Celia Andreu-Agullo, Helen S. Tian, Subhasree Sridhar
Science Advances. 2021-10-08 - 17 citationsPhase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.Anthony W Tolcher, Michael Gordon, Kathleen M Mahoney, Anna Seto, Marianna Zavodovskaya
Journal for Immunotherapy of Cancer. 2023-02-01 - 3 citationsPhase 1b study of pan-AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN-mutated advanced solid tumors.Shubham Pant, Erika Hamilton, Susanna V Ulahannan, James F Strauss, Fadi S Braiteh
Cancer. 2023-06-15
Press Mentions
- Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage CancersMay 26th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: